EU regulator prepares to issue advice on use of J&J vaccine
Study helps unravel why pregnant women develop heart failure similar to older patients
20 April 20213 doses, then 1 each year: Why Pfizer, not AstraZeneca, is best for the long haul
20 April 2021EU regulator prepares to issue advice on use of J&J vaccine
Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected in the U.S.
